Thyroid Cancer Trial, Recruiting (NCT02609685)

Thyroid Cancer Trial, Recruiting NCT02609685 Sponsor: Cedars-Sinai Medical Center Condition: Thyroid Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT02609685 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Thyroid Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Your thyroid nodule has been tested and found to be either highly suspicious or confirmed as a type of thyroid cancer called papillary thyroid carcinoma, or it has a specific gene change called a BRAF mutation (confirm with trial site for exact biopsy category)
Your thyroid nodule is 2.0 centimeters (about ¾ of an inch) or smaller, as measured by ultrasound
You are willing and able to sign a consent form agreeing to take part in the study
You can read and write English fluently, as the study includes questionnaires

Who may not be able to join:

Your thyroid cancer is a more aggressive or fast-growing type (confirm with trial site)
There are signs that the cancer may have spread to lymph nodes in the front or sides of your neck
Your thyroid nodule is in a location that makes treatment risky, such as being very close to a nerve that controls your voice, or close to your windpipe where it could grow into it
You have had radiation treatment to your neck area in the past

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Allen Ho, MD, Cedars-Sinal Medical Center

Phone: 310-423-1220

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT02609685

Sponsor: Cedars-Sinai Medical Center

Phase: Not Applicable

Status: Recruiting

Condition: Thyroid Cancer

Trial contact: 310-423-1220

More information: https://clinicaltrials.gov/study/NCT02609685

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Your thyroid nodule has been tested and found to be either highly suspicious or confirmed as a type of thyroid cancer called papillary thyroid carcinoma, or it has a specific gene change called a BRAF mutation (confirm with trial site for exact biopsy category)
Your thyroid nodule is 2.0 centimeters (about ¾ of an inch) or smaller, as measured by ultrasound
You are willing and able to sign a consent form agreeing to take part in the study
You can read and write English fluently, as the study includes questionnaires

Who may not be able to join:

Your thyroid cancer is a more aggressive or fast-growing type (confirm with trial site)
There are signs that the cancer may have spread to lymph nodes in the front or sides of your neck
Your thyroid nodule is in a location that makes treatment risky, such as being very close to a nerve that controls your voice, or close to your windpipe where it could grow into it
You have had radiation treatment to your neck area in the past

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Cedars-Sinai Medical Center

Registry

ClinicalTrials.gov

Start date

13 May 2016

Est. completion

1 December 2030

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Rate of disease progression

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov